Lack of CD95/FAS gene somatic mutations in extranodal, nodal and splenic marginal zone B cell lymphomas

F. Bertoni, A. Conconi, S. Luminari, C. Realini, E. Roggero, L. Baldini, S. Carobbio, F. Cavalli, A. Neri, E. Zucca

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Germline CD95 (also known as FAS, APT1 and APO1) gene mutations have been associated with benign lymphoproliferative diseases and autoimmune processes. Somatic mutations have been reported in human tumours, including lymphomas. Since marginal zone B cell lymphomas usually arise in a background of chronic inflammation, often of autoimmune origin, we searched for CD95 gene mutations in an unselected series of marginal zone B cell lymphomas. The CD95/FAS full coding region, comprising exon-intron junctions, was amplified from genomic DNA by polymerase chain reaction (PCR) in 10 separate reactions. PCR products were analysed by single-strand conformation polymorphism (SSCP) and visualised by silver staining. Bands exhibiting an altered electrophoretic mobility were sequenced. Twenty-seven cases of marginal zone B cell lymphomas of whom fresh or frozen tumour material was available (18 extranodal, five splenic and four nodal) were studied. Previously described silent polymorphisms in exons 7 (C836T) and 3 (T416C) were detected in 42% and in 19% of the cases, respectively. One silent T-to-A substitution at bp 431, within exon 3, was found in one case. Our results did not reveal the presence of CD95 somatic mutations in unselected cases of marginal zone B cell lymphomas. On the basis of our data, we cannot rule out that other genes coding for proteins involved in the CD95-induced apoptotic pathway might be altered. However, this pathway does not seem to play an important role in the pathogenesis of these lymphoma subtypes.

Original languageEnglish
Pages (from-to)446-448
Number of pages3
JournalLeukemia
Volume14
Issue number3
Publication statusPublished - 2000

Fingerprint

Marginal Zone B-Cell Lymphoma
Exons
Mutation
Genes
Lymphoma
Polymerase Chain Reaction
Silver Staining
DNA-Directed DNA Polymerase
Introns
Autoimmune Diseases
Neoplasms
Inflammation
Proteins

Keywords

  • CD95
  • FAS
  • MALT
  • Marginal zone B cell lymphoma
  • Mutations

ASJC Scopus subject areas

  • Hematology
  • Cancer Research

Cite this

Bertoni, F., Conconi, A., Luminari, S., Realini, C., Roggero, E., Baldini, L., ... Zucca, E. (2000). Lack of CD95/FAS gene somatic mutations in extranodal, nodal and splenic marginal zone B cell lymphomas. Leukemia, 14(3), 446-448.

Lack of CD95/FAS gene somatic mutations in extranodal, nodal and splenic marginal zone B cell lymphomas. / Bertoni, F.; Conconi, A.; Luminari, S.; Realini, C.; Roggero, E.; Baldini, L.; Carobbio, S.; Cavalli, F.; Neri, A.; Zucca, E.

In: Leukemia, Vol. 14, No. 3, 2000, p. 446-448.

Research output: Contribution to journalArticle

Bertoni, F, Conconi, A, Luminari, S, Realini, C, Roggero, E, Baldini, L, Carobbio, S, Cavalli, F, Neri, A & Zucca, E 2000, 'Lack of CD95/FAS gene somatic mutations in extranodal, nodal and splenic marginal zone B cell lymphomas', Leukemia, vol. 14, no. 3, pp. 446-448.
Bertoni F, Conconi A, Luminari S, Realini C, Roggero E, Baldini L et al. Lack of CD95/FAS gene somatic mutations in extranodal, nodal and splenic marginal zone B cell lymphomas. Leukemia. 2000;14(3):446-448.
Bertoni, F. ; Conconi, A. ; Luminari, S. ; Realini, C. ; Roggero, E. ; Baldini, L. ; Carobbio, S. ; Cavalli, F. ; Neri, A. ; Zucca, E. / Lack of CD95/FAS gene somatic mutations in extranodal, nodal and splenic marginal zone B cell lymphomas. In: Leukemia. 2000 ; Vol. 14, No. 3. pp. 446-448.
@article{142a2cc1f98d463b8395fcb3b8e48159,
title = "Lack of CD95/FAS gene somatic mutations in extranodal, nodal and splenic marginal zone B cell lymphomas",
abstract = "Germline CD95 (also known as FAS, APT1 and APO1) gene mutations have been associated with benign lymphoproliferative diseases and autoimmune processes. Somatic mutations have been reported in human tumours, including lymphomas. Since marginal zone B cell lymphomas usually arise in a background of chronic inflammation, often of autoimmune origin, we searched for CD95 gene mutations in an unselected series of marginal zone B cell lymphomas. The CD95/FAS full coding region, comprising exon-intron junctions, was amplified from genomic DNA by polymerase chain reaction (PCR) in 10 separate reactions. PCR products were analysed by single-strand conformation polymorphism (SSCP) and visualised by silver staining. Bands exhibiting an altered electrophoretic mobility were sequenced. Twenty-seven cases of marginal zone B cell lymphomas of whom fresh or frozen tumour material was available (18 extranodal, five splenic and four nodal) were studied. Previously described silent polymorphisms in exons 7 (C836T) and 3 (T416C) were detected in 42{\%} and in 19{\%} of the cases, respectively. One silent T-to-A substitution at bp 431, within exon 3, was found in one case. Our results did not reveal the presence of CD95 somatic mutations in unselected cases of marginal zone B cell lymphomas. On the basis of our data, we cannot rule out that other genes coding for proteins involved in the CD95-induced apoptotic pathway might be altered. However, this pathway does not seem to play an important role in the pathogenesis of these lymphoma subtypes.",
keywords = "CD95, FAS, MALT, Marginal zone B cell lymphoma, Mutations",
author = "F. Bertoni and A. Conconi and S. Luminari and C. Realini and E. Roggero and L. Baldini and S. Carobbio and F. Cavalli and A. Neri and E. Zucca",
year = "2000",
language = "English",
volume = "14",
pages = "446--448",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Lack of CD95/FAS gene somatic mutations in extranodal, nodal and splenic marginal zone B cell lymphomas

AU - Bertoni, F.

AU - Conconi, A.

AU - Luminari, S.

AU - Realini, C.

AU - Roggero, E.

AU - Baldini, L.

AU - Carobbio, S.

AU - Cavalli, F.

AU - Neri, A.

AU - Zucca, E.

PY - 2000

Y1 - 2000

N2 - Germline CD95 (also known as FAS, APT1 and APO1) gene mutations have been associated with benign lymphoproliferative diseases and autoimmune processes. Somatic mutations have been reported in human tumours, including lymphomas. Since marginal zone B cell lymphomas usually arise in a background of chronic inflammation, often of autoimmune origin, we searched for CD95 gene mutations in an unselected series of marginal zone B cell lymphomas. The CD95/FAS full coding region, comprising exon-intron junctions, was amplified from genomic DNA by polymerase chain reaction (PCR) in 10 separate reactions. PCR products were analysed by single-strand conformation polymorphism (SSCP) and visualised by silver staining. Bands exhibiting an altered electrophoretic mobility were sequenced. Twenty-seven cases of marginal zone B cell lymphomas of whom fresh or frozen tumour material was available (18 extranodal, five splenic and four nodal) were studied. Previously described silent polymorphisms in exons 7 (C836T) and 3 (T416C) were detected in 42% and in 19% of the cases, respectively. One silent T-to-A substitution at bp 431, within exon 3, was found in one case. Our results did not reveal the presence of CD95 somatic mutations in unselected cases of marginal zone B cell lymphomas. On the basis of our data, we cannot rule out that other genes coding for proteins involved in the CD95-induced apoptotic pathway might be altered. However, this pathway does not seem to play an important role in the pathogenesis of these lymphoma subtypes.

AB - Germline CD95 (also known as FAS, APT1 and APO1) gene mutations have been associated with benign lymphoproliferative diseases and autoimmune processes. Somatic mutations have been reported in human tumours, including lymphomas. Since marginal zone B cell lymphomas usually arise in a background of chronic inflammation, often of autoimmune origin, we searched for CD95 gene mutations in an unselected series of marginal zone B cell lymphomas. The CD95/FAS full coding region, comprising exon-intron junctions, was amplified from genomic DNA by polymerase chain reaction (PCR) in 10 separate reactions. PCR products were analysed by single-strand conformation polymorphism (SSCP) and visualised by silver staining. Bands exhibiting an altered electrophoretic mobility were sequenced. Twenty-seven cases of marginal zone B cell lymphomas of whom fresh or frozen tumour material was available (18 extranodal, five splenic and four nodal) were studied. Previously described silent polymorphisms in exons 7 (C836T) and 3 (T416C) were detected in 42% and in 19% of the cases, respectively. One silent T-to-A substitution at bp 431, within exon 3, was found in one case. Our results did not reveal the presence of CD95 somatic mutations in unselected cases of marginal zone B cell lymphomas. On the basis of our data, we cannot rule out that other genes coding for proteins involved in the CD95-induced apoptotic pathway might be altered. However, this pathway does not seem to play an important role in the pathogenesis of these lymphoma subtypes.

KW - CD95

KW - FAS

KW - MALT

KW - Marginal zone B cell lymphoma

KW - Mutations

UR - http://www.scopus.com/inward/record.url?scp=0034096184&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034096184&partnerID=8YFLogxK

M3 - Article

C2 - 10720140

AN - SCOPUS:0034096184

VL - 14

SP - 446

EP - 448

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 3

ER -